A Hong Kong biotech company said its therapeutic HIV vaccine showed “promising” results in a recent clinical trial, taking it ...
HONG KONG SAR - Media OutReach Newswire – 12 November 2024 - Immuno Cure BioTech (" Immuno Cure "), a clinical-stage ...
The project, aptly named BRILLIANT, an acronym for “Bringing Innovation to Clinical and Laboratory Research to End HIV in ...
Nigeria, South Africa, Zambia, Zimbabwe, Tanzania, Uganda, Kenya, and Mozambique have begun locally-led HIV vaccine research and development. This was disclosed at a press briefing in Abuja, on ...
Immuno Cure is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development ...
The federal government yesterday formally announced the commencement of the HIV Vaccine Innovation, Science, and Technology ...
The National Agency for the Control of AIDS (NACA has expressed enthusiasm over the involvement of an indigenous research institute in groundbreaking HIV vaccine development efforts. This comes ...
The Physicians Committee—and 27 other organizations—are calling on Congress to reject funding for harmful primate experiments ...
As the science stands, the vast majority of the roughly eight million people in South Africa living with HIV will have to get ...
Highly effective treatments for HIV have existed since the mid-1990s. But while these treatments keep people healthy, we do not yet have a safe and scalable way to completely rid the body of the virus ...